These findings provided further support for the cytokine hypothesis of PSD during the acute phase of stroke and also suggested that the rs9657182 polymorphism and serum IDO1 levels might be novel diagnostic biomarkers and/or intervention targets for early-onset PSD. Here, IDO1 is linked to stroke disorder.